文献速递淋巴瘤

MALT淋巴瘤患者生存预测因素:一项回顾性病例对照研究

Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study.
PubMed 文献 · Blood Adv · 2023-01-01

该研究回顾了2000至2012年在纪念斯隆凯特琳癌症中心诊断的593例MALT淋巴瘤患者,中位年龄60岁,72%为I/II期,中位随访9.2年。10年总生存率75%,淋巴瘤特异性死亡率4%,竞争性非淋巴瘤死亡率21%;总体标准化死亡比为1.41(95%CI 1.19-1.67;P<.001)。多因素分析显示年龄较大、晚期疾病和体能状态差与较差总生存独立相关;年轻患者总生存较好但相对生存较差;疾病播散是淋巴瘤特异性死亡风险因素。

要点

  • MALT淋巴瘤诊断与中等程度的生存受损相关,总体标准化死亡比1.41(95%CI 1.19-1.67;P<.001)。
  • 年龄较大、晚期疾病和体能状态差是总生存的独立不良预后因素。
  • 疾病播散与淋巴瘤特异性死亡增加相关,年龄较大与非淋巴瘤原因死亡相关。

核心结论

  • 总体而言,MALT淋巴瘤诊断与中等程度的生存受损相关。
  • 年龄和晚期疾病是最重要的预后因素;年轻患者总生存较好但相对生存较差。
  • 疾病播散是淋巴瘤特异性死亡的风险因素。

研究设计与样本

  • 回顾性病例对照研究,纳入2000至2012年在纪念斯隆凯特琳癌症中心诊断的593例MALT淋巴瘤患者,中位年龄60岁,72%为I/II期。
  • 中位随访9.2年,采用粗总生存率和标准化死亡比计算的相对生存率分析结局。

主要发现

  • 10年总生存率75%,淋巴瘤特异性死亡率4%,竞争性非淋巴瘤死亡率21%。
  • 总体标准化死亡比为1.41(95%CI 1.19-1.67;P<.001)。
  • 多因素分析显示年龄较大、晚期疾病和体能状态差与较差总生存独立相关。
  • 年龄≥70岁、I期、皮肤或胃起源等亚组的相对生存与正常匹配人群相似。
  • 淋巴瘤特异性死亡增加与疾病播散相关,非淋巴瘤原因死亡与年龄较大相关。

关键数值与推荐

  • 总体标准化死亡比1.41(95%CI 1.19-1.67;P<.001)。
  • 10年总生存率75%,淋巴瘤特异性死亡率4%,竞争性非淋巴瘤死亡率21%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is limited understanding of the extent to which mucosa-associated lymphoid tissue (MALT) lymphoma affects a patient's risk of death and how classically considered prognostic factors affect lymphoma-specific vs other noncancer mortality. This study analyzed major long-term outcomes of patients with MALT lymphoma and the prognostic significance of baseline clinical features. We reviewed the clinical features, treatments, disease course, and survival of 593 patients with MALT lymphoma diagnosed at Memorial Sloan Kettering between 2000 to 2012. Outcomes were analyzed using crude overall survival (OS) and relative survival (RS) by standardized mortality ratio. The median age was 60 years, 72% were at stage I/II. With a median follow-up of 9.2 years, the 10-year OS, lymphoma-specific mortality, and competing nonlymphoma mortality was 75%, 4%, and 21%, respectively; the overall standardized mortality ratio was 1.41 (95% confidence interval, 1.19-1.67; P < .001). Using multivariate analysis, older age, advanced stage, and poor performance status were independently associated with inferior OS. Several subgroups had similar RS to the normal matched population, including those with an age of ≥70 years, stage I, and skin or gastric origin. Increased lymphoma-specific death was associated with spread disease, whereas death from nonlymphoma causes was correlated with older age. Overall, a diagnosis of MALT lymphoma was associated with moderately compromised survival. Age and advanced-stage disease emerged as the most important prognostic factors. Younger patients had better OS but worse RS. Disease dissemination was the lymphoma-specific risk factor.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Qi S, Liu X, Noy A, et al. Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study. Blood Adv. 2023. PMID: 36399527. doi:10.1182/bloodadvances.2022007772

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。